Skip to main content

Validation of Actionable Genomic ABerrations in a paediatric Oncology Network for Doctorate students

Objective

Pre-clinical drug development for paediatric cancers is very complex, resource intensive and requiring multi-disciplinary expertise and innovative approaches. The VAGABOND ITN, consisting of 12 academic and 6 non-academic partners from 8 European countries, aims to create a multidisciplinary and multi-sectoral program to validate new therapeutic interventions in paediatric cancer. This network will be sustainable embedded in the ITCC (Innovative Treatments for Children with Cancer) Consortium. The VAGABOND ITN will focus on 15 cutting-edge research projects studying molecular, epigenetic and immunological targets. All projects will (partly) include target identification, in vitro and in vivo validation, compound testing and preparation for clinical implementation. This consortium will highly stimulate international education and multi-disciplinary exchange of expertise in the different steps of pre-clinical drug development. This setting provides an opportunity for a unique European training network in which early stage researchers are equipped with a broad knowledge in pre-clinical drug development. Through this network students will gain access to other leading academic research groups, specialized multi-sectoral companies and the most innovative techniques and insights in the complexity of translational medicine to prepare them for future challenges in their career pathway. In this collaboration we will increase the commune expertise on tumour types and technical expertise for target validation. This will improve the implementation of interventions across paediatric cancer and strongly reduce the timeline from bench to the bedside.

Field of science

  • /medical and health sciences/clinical medicine/oncology/cancer

Call for proposal

H2020-MSCA-ITN-2020
See other projects for this call

Funding Scheme

MSCA-ITN-ETN - European Training Networks

Coordinator

PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV
Address
Heidelberglaan 25
3584CS Utrecht
Netherlands
Activity type
Other
EU contribution
€ 796 859,64

Participants (10)

INSTITUT CURIE
France
EU contribution
€ 549 604,08
Address
Rue D'ulm 26
75231 Paris
Activity type
Research Organisations
DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG
Germany
EU contribution
€ 505 576,80
Address
Im Neuenheimer Feld 280
69120 Heidelberg
Activity type
Research Organisations
ST. ANNA KINDERKREBSFORSCHUNG
Austria
EU contribution
€ 264 207,24
Address
Zimmermannplatz 10
1090 Wien
Activity type
Research Organisations
LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN
Germany
EU contribution
€ 252 788,40
Address
Geschwister Scholl Platz 1
80539 Muenchen
Activity type
Higher or Secondary Education Establishments
UNIVERSITAT ZURICH
Switzerland
EU contribution
€ 281 276,64
Address
Ramistrasse 71
8006 Zurich
Activity type
Higher or Secondary Education Establishments
THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL
United Kingdom
EU contribution
€ 303 172,56
Address
Old Brompton Road 123
SW7 3RP London
Activity type
Higher or Secondary Education Establishments
CHARITE - UNIVERSITAETSMEDIZIN BERLIN
Germany
EU contribution
€ 252 788,40
Address
Chariteplatz 1
10117 Berlin
Activity type
Higher or Secondary Education Establishments
ISTITUTO ORTOPEDICO RIZZOLI
Italy
EU contribution
€ 261 499,68
Address
Via Di Barbiano 1/10
40136 Bologna
Activity type
Research Organisations
UNIVERSITEIT GENT
Belgium
EU contribution
€ 256 320
Address
Sint Pietersnieuwstraat 25
9000 Gent
Activity type
Higher or Secondary Education Establishments
GADETA BV
Netherlands
EU contribution
€ 265 619,88
Address
Yalelaan 62
3584 CM Utrecht
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)